Skip to main content
. 2016 Apr 12;7(19):28556–28569. doi: 10.18632/oncotarget.8699

Figure 4. MiR-21 and miR-155 are elevated in pancreatic malignancy in independent EUS-FNA and FFPE cohorts.

Figure 4

Displayed are the expression levels measured by qRT-PCR across tissue-types for (A) miR-21 and (B) miR-155 in EUS-FNAs; and (C) miR-21 and (D) miR-155 in FFPE samples (*P < 0.050).